Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.

Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.

Item
http://www.wikidata.org/entity/Q36902706
Effects and mechanisms of PPARalpha activator fenofibrate on myocardial remodelling in hypertension.Maternal obesity induces fibrosis in fetal myocardium of sheepHigh-salt diet during pregnancy and angiotensin-related cardiac changes.Role of mitochondrial dysfunction in insulin resistance.Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus.Ultrastructure Study of Transgenic Ren2 Rat Aorta - Part 1: Endothelium and IntimaCardiac-specific down-regulation of carnitine palmitoyltransferase-1b (CPT-1b) prevents cardiac remodeling in obese mice.HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome.
P2860

Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.

Item
http://www.wikidata.org/entity/Q36902706
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.
@en
type
label
Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.
@en
prefLabel
Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P356
P1433
P1476
Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1559-4564.2006.05626.X
P433
P478
P577
P5875
P698